Honglian Tao Selected Research

Doxycycline (Periostat)

1/2022	Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer.
1/2020	Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Honglian Tao Research Topics

Disease

2	Hepatocellular Carcinoma (Hepatoma) 02/2022 - 01/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2020
2	Neoplasms (Cancer) 01/2020 - 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 11/2018

Drug/Important Bio-Agent (IBA)

2	PentosesIBA 02/2022 - 01/2019
2	Thymidine PhosphorylaseIBA 02/2022 - 01/2019
2	Doxycycline (Periostat)FDA LinkGeneric 01/2022 - 01/2020
1	Volatile Fatty AcidsIBA 01/2021
1	Hempa (Hexamethylphosphoramide)IBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2020
1	Therapeutic UsesIBA 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 01/2020
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	tipiracilIBA 01/2019
1	Actins (F Actin)IBA 11/2018
1	transgelinIBA 11/2018